Enobosarm, also formerly known as ostarine and by the developmental code names GTx-024, MK-2866, and S-22, is a selective androgen receptor modulator...
116 KB (12,937 words) - 22:13, 22 October 2024
A-sample result for enobosarm. UFC Fighter Tim Means was pulled from a fight in February 2017 after testing positive for enobosarm in a pre-fight drug...
56 KB (5,806 words) - 21:02, 8 November 2024
Phase I and II trials have provided preliminary evidence that the SARMs enobosarm and GSK-2881078 (in elderly men and postmenopausal women), and OPL-88004...
75 KB (6,812 words) - 20:55, 24 November 2024
described in 2010. It is less clinically studied than other SARMs like enobosarm, with only a few small clinical trials having been conducted and reported...
55 KB (5,985 words) - 21:57, 25 May 2024
receptor modulator (SARM) classes. Its drugs in development included enobosarm (ostarine) and GTx-758. The company was founded in Memphis in 1997 by...
7 KB (627 words) - 22:13, 22 November 2024
like the selective androgen receptor modulators (SARMs) andarine and enobosarm (ostarine) are not included here. The 17α-ethenylated (vinylated) testosterone...
25 KB (654 words) - 16:34, 13 December 2024
like the selective androgen receptor modulators (SARMs) andarine and enobosarm (ostarine) are not included here. Marketed Androstenediol (A5; 5-androstenediol)...
9 KB (376 words) - 17:45, 11 November 2023
GTx-027 is a nonsteroidal arylpropionamide SARM and is an analogue of enobosarm (ostarine; GTx-024). GTx-027 was first described in the scientific literature...
9 KB (718 words) - 20:20, 13 November 2024
discontinued, in favor of the structurally related and improved compound enobosarm (ostarine; GTx-024; S-22). Andarine is an orally active partial agonist...
10 KB (960 words) - 03:05, 14 November 2024
Internet. Aside from vosilasarm, the other most commonly used SARMs include enobosarm (ostarine; GTx-024, S-22), LGD-4033 (VK5211; "ligandrol"), and andarine...
27 KB (2,530 words) - 11:05, 5 March 2024
as being reminiscent of but distinct from the arylpropionamides (e.g., enobosarm). JNJ-37654032 did not advance past the preclinical research and was never...
6 KB (531 words) - 15:59, 8 November 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
80 KB (6,706 words) - 22:54, 12 December 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
27 KB (2,274 words) - 19:43, 12 November 2024
World Athletics after testing positive for the banned substances S-23 and Enobosarm. Six months later, the IOC formally requested Team GB to collect the medals...
37 KB (1,842 words) - 16:08, 24 September 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
23 KB (1,906 words) - 14:31, 24 November 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
149 KB (15,719 words) - 16:46, 9 December 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
76 KB (7,429 words) - 07:27, 28 December 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
209 KB (21,556 words) - 17:46, 20 December 2024
Barnette KG, Steiner MS, Brufsky A, Overmoyer B (2021). "Efficacy of enobosarm, a selective androgen receptor (AR) targeting agent, correlates with the...
35 KB (4,222 words) - 23:08, 26 November 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
182 KB (17,411 words) - 02:00, 26 December 2024
Cells (CTC) and Reduced Tumor Size "FDA Grants Fast Track Designation to Enobosarm in AR+, ER+, HER2- Metastatic Breast Cancer". Cancer Network. 10 January...
28 KB (3,411 words) - 03:40, 14 June 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
50 KB (4,376 words) - 23:55, 20 December 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
125 KB (11,568 words) - 04:18, 21 December 2024
archger.2015.06.020. PMID 26169182. Srinath R, Dobs A (February 2014). "Enobosarm (GTx-024, S-22): a potential treatment for cachexia". Future Oncology...
30 KB (3,515 words) - 23:54, 3 September 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
83 KB (7,903 words) - 02:07, 10 December 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
4 KB (244 words) - 15:55, 28 October 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
129 KB (13,280 words) - 19:16, 22 December 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
84 KB (8,686 words) - 07:48, 29 December 2024
against South Korea after a positive out-of-competition drug test for Enobosarm. Only players whose teams advanced to the semifinals are ranked. The awards...
46 KB (871 words) - 14:20, 11 August 2024
(acetamidoxolutamide, androxolutamide, GTx-007, S-4) BMS-564,929 DTIB Enobosarm (ostarine, MK-2866, GTx-024, S-22) FTBU-1 GLPG-0492 GSK2881078 GSK-4336A...
49 KB (4,707 words) - 18:10, 1 January 2025